Chimeric antigen receptor (CAR) t-cell therapy

Category: Chimeric antigen receptor (CAR) t-cell therapy

Partnering in Care: Chronic Lymphocytic Leukemia (CLL)

In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic […]

Breaking Down Primary CNS Lymphoma: From Rare Diagnosis to Growing Progress

Primary Central Nervous System Lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the brain, spinal cord, or […]

CAR T-cell Therapy: Your Questions Answered

Curious about CAR T-cell therapy? We went straight to the source for answers. In this episode, the LLS Patient Education […]

Impact of Disparity: Navigating Treatment Equality in Cancer Care

In this episode, we sit down with Dr. Bilal Abid from University of Texas Health Science Center in Houston to […]

Hope on the Horizon: Chronic Lymphocytic Leukemia

Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers.   However, there is a […]

Innovative Therapies: Transforming Non-Hodgkin Lymphoma Care

The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell […]

Cellular Revolution: CAR T-cell Therapy

Explore the cutting-edge of oncology as we delve into the revolutionary world of CAR T-cell therapy, a more recent medical […]

How New Therapies Are Changing The Future of Myeloma

Remarkable progress has been made in the treatment of myeloma over the past decade, giving patients and families much hope […]

Attacking the Cancer Cell: Advances in CAR T-Cell Therapy

Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial […]

Statistics Don’t Color My Outcome: A CAR T-cell Therapy Success

Join us as we speak to Laurie Adami, a follicular lymphoma (non-Hodgkin lymphoma) survivor. In this episode, Laurie shares her […]

Achieving Long-term Remission with Chronic Lymphocytic Leukemia (CLL)

Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses […]

Mantle Cell Lymphoma (MCL) Part Two: CAR T-Cell Therapy

Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part Two of […]

Patient-Doctor Perspectives: Hope in the Uncertainty of AML

Join us as we speak with Charles Huang and Dr. Gabriel Mannis in honor of AML Awareness Day (April 21st). […]

Hope for Rare Cancers: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell […]

Patient-Doctor Perspectives: CLL and a Decade of Transformation

Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a […]

How CAR T-cell Therapy Gives Hope to Cancer Patients

Join us as we speak to Dr. Caron Jacobson, an Assistant Professor of Medicine at Harvard Medical School and a […]

Tackling Lymphoma: Recent Advances in Immunotherapy

Join us as we report on the latest developments in immunotherapy from the 62nd American Society of Hematology (ASH) Annual […]

“The Only Way Through It, Is Through It”: Tim Card’s Story

They say hindsight is always 20/20. Looking back, Tim Card remembers how his body may have been sending signals that […]

How CAR T-cell Therapy Saved My Life: Chuck’s Story

On this episode, Alicia and Lizette speak with Chuck Colletti, a two-time survivor of Stage 4 follicular lymphoma. Chuck was […]

CAR T-cell Explained: Recovering from CAR T-cell Therapy

On this episode, Alicia and Lizette speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist […]

CAR T-cell Therapy Explained: What Is It and How Does It Work?

Join Alicia and Lizette as they speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist […]

CAR T-Cell Therapy Explained: Understanding Potential Side Effects

Like any therapy that is administered in oncology, there is great promise but also, unfortunately, several toxicities and side effects […]

Scroll to Top